Add BrightSurf on Google Email

Science News for November 11, 2023


International clinical trial finds that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity who don’t have diabetes

A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.

SourceCleveland Clinic·JournalNew England Journal of Medicine·DateNov 11, 2023

Cut salt, cut blood pressure

A new study from Northwestern University and Vanderbilt University Medical Center found that reducing sodium intake by just one teaspoon a day can lower systolic blood pressure by about 6 millimeters of mercury, comparable to the effect produced by commonly used first-line medication for high blood pressure. The study involved middle-a...

SourceNorthwestern University·JournalJAMA·TypeRandomized controlled/clinical trial·DateNov 11, 2023

New study finds coronary calcium scores highly effective in identifying heart disease in people without any known risk factors

A new study by Intermountain Health found that high levels of coronary calcium are common among people who have a heart attack but no known risk factors. The study suggests that scans to detect plaque buildup should be part of standard care for these patients, enabling early diagnosis and treatment.

SourceIntermountain Healthcare·TypeObservational study·DateNov 11, 2023

Cut salt, cut blood pressure

A study from Vanderbilt University Medical Center found that reducing sodium intake by just one teaspoon a day can lower systolic blood pressure by about 6 millimeters of mercury. Most people, regardless of whether they are already on blood pressure medications or not, can see a reduction in their blood pressure if they lower the sodiu...